loading
Precedente Chiudi:
$3.03
Aprire:
$3.05
Volume 24 ore:
299
Relative Volume:
0.00
Capitalizzazione di mercato:
$9.46M
Reddito:
-
Utile/perdita netta:
$2.81M
Rapporto P/E:
-0.2167
EPS:
-14.3497
Flusso di cassa netto:
$7.14M
1 W Prestazione:
-1.30%
1M Prestazione:
-0.67%
6M Prestazione:
-18.18%
1 anno Prestazione:
-32.85%
Intervallo 1D:
Value
$3.0411
$3.13
Intervallo di 1 settimana:
Value
$2.96
$3.29
Portata 52W:
Value
$2.51
$4.80

Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile

Name
Nome
Kiora Pharmaceuticals Inc
Name
Telefono
781-788-8869
Name
Indirizzo
332 ENCINITAS BOULEVARD, ENCINITAS
Name
Dipendente
12
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
KPRX's Discussions on Twitter

Confronta KPRX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
KPRX
Kiora Pharmaceuticals Inc
3.1091 9.13M 0 2.81M 7.14M -14.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.29 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.80 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.34 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
570.41 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.31 29.19B 3.81B -644.79M -669.77M -6.24

Kiora Pharmaceuticals Inc Borsa (KPRX) Ultime notizie

pulisher
12:44 PM

What drives Kiora Pharmaceuticals Inc. stock priceConsistent high-performance stocks - Autocar Professional

12:44 PM
pulisher
06:30 AM

Kiora Pharmaceuticals Inc. Stock Analysis and ForecastExtraordinary market timing - Autocar Professional

06:30 AM
pulisher
Jul 22, 2025

KPRX Receives Positive Outlook Following New U.S. Patent | KPRX Stock News - GuruFocus

Jul 22, 2025
pulisher
Jul 22, 2025

Kiora Pharmaceuticals stock rises after receiving patent for KIO-104 By Investing.com - Investing.com Nigeria

Jul 22, 2025
pulisher
Jul 22, 2025

Kiora Pharmaceuticals receives patent for ocular disease treatment - Investing.com

Jul 22, 2025
pulisher
Jul 22, 2025

Kiora Secures Crucial Patent for Eye Disease Drug KIO-104 as Phase 2 Trial Advances - Stock Titan

Jul 22, 2025
pulisher
Jul 21, 2025

What analysts say about Kiora Pharmaceuticals Inc. stockFree Expert Stock Watchlist - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

Is Kiora Pharmaceuticals Inc. a good long term investmentExceptional earning trajectories - jammulinksnews.com

Jul 21, 2025
pulisher
Jul 17, 2025

Why Kiora Pharmaceuticals Inc. stock attracts strong analyst attentionFree Top-Rated Stock Analysis - Newser

Jul 17, 2025
pulisher
Jul 17, 2025

Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know - MSN

Jul 17, 2025
pulisher
Jul 16, 2025

Retinitis Pigmentosa Treatment Market Driven by Gene Therapy - openPR.com

Jul 16, 2025
pulisher
Jul 15, 2025

How Kiora Pharmaceuticals Inc. stock performs during market volatilityFree Smart Money Stock Analysis - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Kiora Pharmaceuticals Inc. stock price move sharplyPredictable Return Stock Picks - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

Kiora Pharmaceuticals (NASDAQ:KPRX) Trading 1.8% Higher – Here’s Why - Defense World

Jul 09, 2025
pulisher
Jun 17, 2025

Kiora Pharmaceuticals (NASDAQ:KPRX) Trading Down 0.3% – Here’s Why - Defense World

Jun 17, 2025
pulisher
Jun 05, 2025

Kiora Pharmaceuticals and Senju Pharmaceutical partner on KIO-301 for retinal disease treatment in Asia - Ophthalmology Times

Jun 05, 2025
pulisher
Jun 04, 2025

kiora pharmaceuticals reports results of annual shareholder meeting By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

kiora pharmaceuticals reports results of annual shareholder meeting - Investing.com

Jun 04, 2025
pulisher
Jun 04, 2025

Kiora Pharmaceuticals Holds Annual Meeting, Elects Directors - TipRanks

Jun 04, 2025
pulisher
Jun 04, 2025

Oil Prices Climb While US Equity Futures Stutter - Finimize

Jun 04, 2025
pulisher
Jun 04, 2025

MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard SurgeMore Stocks Inside! - openPR.com

Jun 04, 2025
pulisher
Jun 04, 2025

Pre-market Movers: STSS, SGMT, NIVF, OGEN... - RTTNews

Jun 04, 2025
pulisher
Jun 04, 2025

MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard Surge – More Stocks Inside! - FinancialContent

Jun 04, 2025
pulisher
Jun 04, 2025

Markets | American Financial Group, Inc. - FinancialContent

Jun 04, 2025
pulisher
Jun 04, 2025

Kiora Pharmaceuticals inks potential $110 million deal with Senju By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 03, 2025

ReShape Lifesciences And Kiora Pharma Impress Investors, Dollar General Uplifts Outlook - Finimize

Jun 03, 2025
pulisher
Jun 03, 2025

Sector Update: Health Care - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Kiora Pharmaceuticals Stock Skyrockets Over 20% in Dynamic Trading Session - Daily Chhattisgarh News

Jun 03, 2025
pulisher
Jun 03, 2025

Traws Pharma Inc. Stock Skyrockets Over 40%, Then Pares Gains in Volatile Trading - Daily Chhattisgarh News

Jun 03, 2025
pulisher
Jun 03, 2025

Pre-market Movers: NIVF, TRAW, KKR, AGEN... - RTTNews

Jun 03, 2025
pulisher
Jun 03, 2025

Kiora PharmaceuticalsEnters Exclusive Option Agreement With SenjuSEC Filing - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Kiora Pharmaceuticals inks potential $110 million deal with Senju - Investing.com

Jun 03, 2025

Kiora Pharmaceuticals Inc Azioni (KPRX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Kiora Pharmaceuticals Inc Azioni (KPRX) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Shapiro Aron
Director
Sep 10 '24
Buy
3.60
3,000
10,800
3,000
Walters-Hoffert Lisa
Director
Aug 19 '24
Buy
3.86
1,250
4,825
1,250
TYLE PRAVEEN
Director
Aug 19 '24
Buy
3.96
5,000
19,800
5,014
Tosca Melissa
CFO
Aug 14 '24
Buy
3.21
2,000
6,420
13,599
$22.80
price up icon 4.56%
$36.00
price down icon 0.33%
$102.46
price down icon 0.38%
$27.75
price up icon 4.50%
$113.56
price up icon 1.86%
biotechnology ONC
$295.32
price down icon 0.11%
Capitalizzazione:     |  Volume (24 ore):